{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T04:02:12Z","timestamp":1793073732172,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1245\/s10434-024-16328-z","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T14:02:35Z","timestamp":1728482555000},"page":"199-208","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Insight into Predictors of Cytoreduction Score Following Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy for Gastric Peritoneal Carcinomatosis Improves Patient Selection and Prognostic Outcomes"],"prefix":"10.1245","volume":"32","author":[{"given":"Ahmed B.","family":"Hamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudy","family":"El Asmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Tirukkovalur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Tcharni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis","family":"Tatsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Jelinek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Derby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genia","family":"Dubrovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Nunns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Ongchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James F.","family":"Pingpank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amer H.","family":"Zureikat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aatur","family":"Singhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Haroon","family":"Choudry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9403-7503","authenticated-orcid":false,"given":"Samer S.","family":"AlMasri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,9]]},"reference":[{"issue":"3","key":"16328_CR1","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.cgh.2019.07.045","volume":"18","author":"AP Thrift","year":"2020","unstructured":"Thrift AP, El-Serag HB. Burden of gastric cancer. Clin Gastroenterol Hepatol. 2020;18(3):534\u201342. https:\/\/doi.org\/10.1016\/j.cgh.2019.07.045.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"16328_CR2","doi-asserted-by":"publisher","unstructured":"Wang Z, Graham DY, Khan A, et al. Incidence of gastric cancer in the USA during 1999 to 2013: a 50-state analysis. Int J Epidemiol. 2018;47(3):966\u2013975. https:\/\/doi.org\/10.1093\/ije\/dyy055","DOI":"10.1093\/ije\/dyy055"},{"issue":"3","key":"16328_CR3","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.giec.2021.03.001","volume":"31","author":"AP Thrift","year":"2021","unstructured":"Thrift AP, Nguyen TH. Gastric cancer epidemiology. Gastrointest Endosc Clin N Am. 2021;31(3):425\u201339. https:\/\/doi.org\/10.1016\/j.giec.2021.03.001.","journal-title":"Gastrointest Endosc Clin N Am."},{"issue":"3","key":"16328_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin."},{"issue":"3","key":"16328_CR5","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/apt.12814","volume":"40","author":"KM Fock","year":"2014","unstructured":"Fock KM. Review article: the epidemiology and prevention of gastric cancer. Aliment Pharmacol Ther. 2014;40(3):250\u201360. https:\/\/doi.org\/10.1111\/apt.12814.","journal-title":"Aliment Pharmacol Ther."},{"issue":"5","key":"16328_CR6","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1245\/s10434-021-11316-z","volume":"29","author":"JF Zhang","year":"2022","unstructured":"Zhang JF, Lv L, Zhao S, Zhou Q, Jiang CG. Hyperthermic intraperitoneal chemotherapy (HIPEC) combined with surgery: a 12-year meta-analysis of this promising treatment strategy for advanced gastric cancer at different stages. Ann Surg Oncol. 2022;29(5):3170\u201386. https:\/\/doi.org\/10.1245\/s10434-021-11316-z.","journal-title":"Ann Surg Oncol."},{"issue":"12","key":"16328_CR7","doi-asserted-by":"publisher","first-page":"7528","DOI":"10.1245\/s10434-022-12312-7","volume":"29","author":"M Martins","year":"2022","unstructured":"Martins M, Santos-Sousa H, Araujo F, Nogueiro J, Sousa-Pinto B. Impact of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer with peritoneal carcinomatosis: a systematic review and meta-analysis. Ann Surg Oncol. 2022;29(12):7528\u201337. https:\/\/doi.org\/10.1245\/s10434-022-12312-7.","journal-title":"Ann Surg Oncol."},{"issue":"8","key":"16328_CR8","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1245\/s10434-019-07450-4","volume":"26","author":"I Manzanedo","year":"2019","unstructured":"Manzanedo I, Pereira F, Rihuete Caro C, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for gastric cancer with peritoneal carcinomatosis: multicenter study of Spanish Group of Peritoneal Oncologic Surgery (GECOP). Ann Surg Oncol. 2019;26(8):2615\u201321. https:\/\/doi.org\/10.1245\/s10434-019-07450-4.","journal-title":"Ann Surg Oncol."},{"key":"16328_CR9","doi-asserted-by":"publisher","unstructured":"Rijken A, Lurvink RJ, Luyer MDP, et al. The burden of peritoneal metastases from gastric cancer: a systematic review on the incidence, risk factors and survival. J Clin Med. 2021;10(21)https:\/\/doi.org\/10.3390\/jcm10214882","DOI":"10.3390\/jcm10214882"},{"key":"16328_CR10","doi-asserted-by":"publisher","unstructured":"Gamboa AC, Winer JH. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastric cancer. Cancers (Basel). 2019;11(11)https:\/\/doi.org\/10.3390\/cancers11111662","DOI":"10.3390\/cancers11111662"},{"key":"16328_CR11","doi-asserted-by":"publisher","unstructured":"Ishigami H, Fujiwara Y, Fukushima R, et al. Phase III trial comparing intraperitoneal and intravenous paclitaxel plus S-1 versus cisplatin plus S-1 in patients with gastric cancer with peritoneal metastasis: PHOENIX-GC Trial. J Clin Oncol. 2018;36(19):1922-1929. https:\/\/doi.org\/10.1200\/JCO.2018.77.8613","DOI":"10.1200\/JCO.2018.77.8613"},{"issue":"9","key":"16328_CR12","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","volume":"15","author":"VJ Verwaal","year":"2008","unstructured":"Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol. 2008;15(9):2426\u201332. https:\/\/doi.org\/10.1245\/s10434-008-9966-2.","journal-title":"Ann Surg Oncol."},{"issue":"6","key":"16328_CR13","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1245\/s10434-011-1631-5","volume":"18","author":"XJ Yang","year":"2011","unstructured":"Yang XJ, Huang CQ, Suo T, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol. 2011;18(6):1575\u201381. https:\/\/doi.org\/10.1245\/s10434-011-1631-5.","journal-title":"Ann Surg Oncol."},{"key":"16328_CR14","doi-asserted-by":"publisher","unstructured":"Bonnot PE, Piessen G, Kepenekian V, et al. Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score analysis. J Clin Oncol. 2019;37(23):2028-2040. https:\/\/doi.org\/10.1200\/JCO.18.01688","DOI":"10.1200\/JCO.18.01688"},{"issue":"2","key":"16328_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s13193-016-0499-z","volume":"7","author":"A Bhatt","year":"2016","unstructured":"Bhatt A, Goere D. Cytoreductive surgery plus HIPEC for peritoneal metastases from colorectal cancer. Indian J Surg Oncol. 2016;7(2):177\u201387. https:\/\/doi.org\/10.1007\/s13193-016-0499-z.","journal-title":"Indian J Surg Oncol."},{"issue":"12","key":"16328_CR16","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1093\/jjco\/hym131","volume":"37","author":"SY Oh","year":"2007","unstructured":"Oh SY, Kwon HC, Lee S, et al. A phase II study of oxaliplatin with low-dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) for gastric cancer patients with malignant ascites. Jpn J Clin Oncol. 2007;37(12):930\u20135. https:\/\/doi.org\/10.1093\/jjco\/hym131.","journal-title":"Jpn J Clin Oncol."},{"issue":"3","key":"16328_CR17","doi-asserted-by":"publisher","first-page":"e266","DOI":"10.3747\/co.23.2831","volume":"23","author":"J Spiliotis","year":"2016","unstructured":"Spiliotis J, Halkia E, de Bree E. Treatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy-current perspectives. Curr Oncol. 2016;23(3):e266\u201375. https:\/\/doi.org\/10.3747\/co.23.2831.","journal-title":"Curr Oncol."},{"key":"16328_CR18","doi-asserted-by":"publisher","unstructured":"Zhuang X, He Y, Ma W. Prophylactic hyperthermic intraperitoneal chemotherapy may benefit the long-term survival of patients after radical gastric cancer surgery. Sci Rep. 2022;12(1):2583. https:\/\/doi.org\/10.1038\/s41598-022-06417-y","DOI":"10.1038\/s41598-022-06417-y"},{"issue":"3","key":"16328_CR19","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1245\/s10434-022-12761-0","volume":"30","author":"BL Green","year":"2023","unstructured":"Green BL, Blumenthaler AN, Gamble LA, et al. Cytoreduction and HIPEC for gastric carcinomatosis: multi-institutional analysis of two phase II clinical trials. Ann Surg Oncol. 2023;30(3):1852\u201360. https:\/\/doi.org\/10.1245\/s10434-022-12761-0.","journal-title":"Ann Surg Oncol."},{"key":"16328_CR20","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.suronc.2019.01.005","volume":"28","author":"T Hotopp","year":"2019","unstructured":"Hotopp T. HIPEC and CRS in peritoneal metastatic gastric cancer\u2014who really benefits? Surg Oncol. 2019;28:159\u201366. https:\/\/doi.org\/10.1016\/j.suronc.2019.01.005.","journal-title":"Surg Oncol."},{"issue":"9","key":"16328_CR21","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1245\/s10434-010-1039-7","volume":"17","author":"O Glehen","year":"2010","unstructured":"Glehen O, Gilly FN, Arvieux C, et al. Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol. 2010;17(9):2370\u20137. https:\/\/doi.org\/10.1245\/s10434-010-1039-7.","journal-title":"Ann Surg Oncol."},{"key":"16328_CR22","doi-asserted-by":"publisher","unstructured":"Sun BJ, Lee B. Review of regional therapies for gastric cancer with peritoneal metastases. Cancers (Basel). 2022;14(3). https:\/\/doi.org\/10.3390\/cancers14030570","DOI":"10.3390\/cancers14030570"},{"key":"16328_CR23","doi-asserted-by":"publisher","unstructured":"Rau B, Lang H, Koenigsrainer A, et al. Effect of hyperthermic intraperitoneal chemotherapy on cytoreductive surgery in gastric cancer with synchronous peritoneal metastases: the phase III GASTRIPEC-I trial. J Clin Oncol. 2024;42(2):146-156. https:\/\/doi.org\/10.1200\/JCO.22.02867","DOI":"10.1200\/JCO.22.02867"},{"issue":"6","key":"16328_CR24","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.ejso.2020.11.139","volume":"47","author":"ZH Ji","year":"2021","unstructured":"Ji ZH, Yu Y, Liu G, et al. Peritoneal cancer index (PCI) based patient selecting strategy for complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis: a single-center retrospective analysis of 125 patients. Eur J Surg Oncol. 2021;47(6):1411\u20139. https:\/\/doi.org\/10.1016\/j.ejso.2020.11.139.","journal-title":"Eur J Surg Oncol."},{"key":"16328_CR25","doi-asserted-by":"publisher","unstructured":"Yonemura Y, Prabhu A, Sako S, et al. Long term survival after cytoreductive surgery combined with perioperative chemotherapy in gastric cancer patients with peritoneal metastasis. Cancers (Basel). 2020;12(1)https:\/\/doi.org\/10.3390\/cancers12010116","DOI":"10.3390\/cancers12010116"},{"key":"16328_CR26","doi-asserted-by":"publisher","unstructured":"Manzanedo I, Pereira F, Perez-Viejo E, Serrano A. Gastric cancer with peritoneal metastases: current status and prospects for treatment. Cancers (Basel). 2023;15(6). https:\/\/doi.org\/10.3390\/cancers15061777","DOI":"10.3390\/cancers15061777"},{"key":"16328_CR27","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2147\/CMAR.S343467","volume":"14","author":"Z Ye","year":"2022","unstructured":"Ye Z, Yu P, Cao Y, et al. Prediction of peritoneal cancer index and prognosis in peritoneal metastasis of gastric cancer using NLR-PLR-DDI score: a retrospective study. Cancer Manag Res. 2022;14:177\u201387. https:\/\/doi.org\/10.2147\/CMAR.S343467.","journal-title":"Cancer Manag Res."},{"key":"16328_CR28","doi-asserted-by":"publisher","unstructured":"Coccolini F, Catena F, Glehen O, et al. Complete versus incomplete cytoreduction in peritoneal carcinosis from gastric cancer, with consideration to PCI cut-off. Systematic review and meta-analysis. Eur J Surg Oncol. 2015;41(7):911-9. https:\/\/doi.org\/10.1016\/j.ejso.2015.03.231","DOI":"10.1016\/j.ejso.2015.03.231"},{"issue":"11","key":"16328_CR29","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1002\/cncr.32868","volume":"126","author":"Chicago Consensus Working Group","year":"2020","unstructured":"Chicago Consensus Working Group. The Chicago Consensus on peritoneal surface malignancies: management of gastric metastases. Cancer. 2020;126(11):2541\u20136. https:\/\/doi.org\/10.1002\/cncr.32868.","journal-title":"Cancer"},{"issue":"5","key":"16328_CR30","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1245\/s10434-014-3985-y","volume":"22","author":"JM Baumgartner","year":"2015","unstructured":"Baumgartner JM, Tobin L, Heavey SF, Kelly KJ, Roeland EJ, Lowy AM. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2015;22(5):1716\u201321. https:\/\/doi.org\/10.1245\/s10434-014-3985-y.","journal-title":"Ann Surg Oncol."},{"issue":"17","key":"16328_CR31","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.21037\/atm-20-1358a","volume":"8","author":"N Zhang","year":"2020","unstructured":"Zhang N, Bai H, Deng J, et al. Impact of examined lymph node count on staging and long-term survival of patients with node-negative stage III gastric cancer: a retrospective study using a Chinese multi-institutional registry with Surveillance, Epidemiology, and End Results (SEER) data validation. Ann Transl Med. 2020;8(17):1075. https:\/\/doi.org\/10.21037\/atm-20-1358a.","journal-title":"Ann Transl Med."},{"key":"16328_CR32","doi-asserted-by":"publisher","unstructured":"Chen XJ, Wei CZ, Lin J, et al. Prognostic significance of PD-L1 expression in gastric cancer patients with peritoneal metastasis. Biomedicines. 2023;11(7)https:\/\/doi.org\/10.3390\/biomedicines11072003","DOI":"10.3390\/biomedicines11072003"},{"key":"16328_CR33","doi-asserted-by":"publisher","unstructured":"Qi C, Chong X, Zhou T, et al. Clinicopathological significance and immunotherapeutic outcome of claudin 18.2 expression in advanced gastric cancer: a retrospective study. Chin J Cancer Res. 2024;36(1):78-89. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2024.01.08","DOI":"10.21147\/j.issn.1000-9604.2024.01.08"},{"issue":"6","key":"16328_CR34","first-page":"1417","volume":"12","author":"S Wang","year":"2011","unstructured":"Wang S, Zheng G, Chen L, Xiong B. Effect of HER-2\/neu over-expression on prognosis in gastric cancer: a meta-analysis. Asian Pac J Cancer Prev. 2011;12(6):1417\u201323.","journal-title":"Asian Pac J Cancer Prev."},{"key":"16328_CR35","doi-asserted-by":"publisher","unstructured":"Koemans WJ, van der Kaaij RT, Boot H, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II). BMC Cancer. 2019;19(1):420. https:\/\/doi.org\/10.1186\/s12885-019-5640-2","DOI":"10.1186\/s12885-019-5640-2"},{"key":"16328_CR36","doi-asserted-by":"publisher","unstructured":"Glehen O, Passot G, Villeneuve L, et al. GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study. BMC Cancer. 2014;14:183. https:\/\/doi.org\/10.1186\/1471-2407-14-183","DOI":"10.1186\/1471-2407-14-183"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-16328-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-16328-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-16328-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T18:04:44Z","timestamp":1734631484000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-16328-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,9]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["16328"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-16328-z","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,9]]},"assertion":[{"value":"20 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have nothing to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}